MDT Stock Chart & Fundamental Analysis

Interactive Chart

About Medtronic PLC

Name

Medtronic PLC

CEO

Geoffrey Straub Martha

Website

www.medtronic.com

Industry

Healthcare

Year Founded

1949

Employees

95,000

Medtronic plc is a medical technology company that develops devices and therapies used in surgical, cardiac, neurological, and diabetes care. The operating model links research with manufacturing, clinician training, and post-market support so new options move from trials to daily practice with consistent standards. Hospitals adopt systems with credentialing and protocols that fit existing routines, while service teams help keep equipment available and therapies monitored. Guidance materials focus on safe initiation and follow-up rather than marketing language, and supply planning aims for continuity once adoption begins. With operations across many regions, Medtronic’s contribution to the healthcare ecosystem is pragmatic: turn engineering into therapies clinicians can trust and patients can live with over the long term.

Analyst Ratings

Consensus Recommendation

Buy5

Hold9

Sell7

Fundamentals & Financials

Revenue (TTM)

$34.7B

Net Income (TTM)

$4.7B

EPS (TTM)

$3.71

ROA (TTM)

5.22%

Current Ratio

2.42

Dividend Yield

0.097%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Income Statement

Item	Q4 2025	Q3 2025	Q2 2025
Revenue	$8,961M	$8,578M	$8,927M
Cost of Sales	$3,556M	$3,632M	$3,147M
Gross Profit	$5,405M	$4,946M	$5,780M
Operating Income	$1,685M	$1,445M	$1,436M
Net Income	$1,374M	$1,040M	$1,057M
EPS	$1.07	$0.81	$0.82

Balance Sheet

Financial Highlights

Dividends History

Split History

Earnings Calendar

Technical Indicators

Medtronic PLC's Technical Indicators Summary

MDT is currently exhibiting a neutral technical profile as the trend strength remains weak with an ADX below 16, indicating limited directional momentum. Momentum indicators like RSI and CCI hover near mid-range levels, suggesting neither strong buying nor selling pressure, while the MACD also signals a hold. The price sits just below several short- and medium-term moving averages, which are trending downward, but remains above the longer-term 200-day averages that continue to offer some support. Volatility, as measured by ATR, is moderate, and volume indicators such as OBV show slight selling pressure. Overall, these mixed signals reflect a market in balance without a clear directional bias. The technical takeaway is that MDT currently maintains a cautious, neutral stance.

Buy

5 signals

Neutral

9 signals

Sell

7 signals

Overall: Neutral43% Neutral signals

Indicator	Value	Signal	Explanation
RSI (14)	44.93	Neutral	RSI (44.93) is neutral.
Stochastic %K (14, 3, 3)	48.73	Neutral	Stochastic (48.73) is neutral.
CCI (20)	-10.92	Neutral	CCI (-10.92) is neutral.
WPR (14)	-74.15	Neutral	Williams %R (-74.15) is neutral.
Momentum (10)	0.71	Buy	Momentum (0.71) is positive.
MFI	45.57	Neutral	MFI (45.57) is neutral.
MACD Level (12, 26)	-0.22	Neutral	Potential bullish reversal: MACD (-0.22) crossed above signal but is still negative.
Bollinger Bands	$95.11 - $100.14	Neutral	Price is within the bands.
ATR (14)	$1.79 (1.85%)	Neutral	Moderate Volatility (1.85%).
ADX (14)	15.98	Neutral	Weak or consolidating trend (ADX < 25). ADX(15.98), +DI(23.23), -DI(23.82)
OBV	127,730,300	Sell	Bearish volume pressure: OBV is below its 20-day SMA. OBV(127,730,300), 20D-SMA-OBV(143,999,920)
Simple Moving Averages	$91.74 - $98.49(5 indicators)	Sell	The price is trading below the short- to mid-term SMAs (10, 20, 50) but remains above the longer-term SMAs (100, 200), indicating near-term weakness within an overall longer-term bullish trend.
Exponential Moving Averages	$93.25 - $97.98(5 indicators)	Sell	The price is trading below the short- to mid-term EMAs (10, 20, 50) but remains above the longer-term EMAs (100, 200), indicating short-term bearishness within an overall longer-term bullish trend.

Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.

Today's Snapshot

End-of-day pricing shows MDT still under yesterday’s 99.49, with the -3.237% gap down leaving it at 96.27. By the final tick, MDT was still positioned ahead of its 2026-02-17 release in 0 days, ending around 96.27. MDT's stock drops amid limited headlines despite FDA clearance for its new surgical robotic system.

Price Change

from $99.49 close

-$3.22

Trading Volume

Above avg 9.5M

14.2M

vs S&P 500 Today

Strong Underperformance

-3.37%

52-Week Position

Mid-range

62.4%